Home

Russell Joseph Harrison

CIK 1592423 · last filed 2018-06-01

Russell Joseph Harrison is a corporate insider who has filed 17 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for SNOAW, was dated Jun 1, 2018. 18 SEC filings were submitted jointly with Oculus Innovative Sciences, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

17

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
OCULUS INNOVATIVE SCIENCES, INC.
1129 NORTH MCDOWELL BLVD.
PETALUMA, CA 94954
Related Filers
Oculus Innovative Sciences, Inc. — 18 joint filings, latest 2018-06-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Director 46,520 — — $0 7 2018-06-01
Sonoma Pharmaceuticals, Inc. (OCLSW) Delisted Director 6,917 — — $0 1 2016-11-30
Sonoma Pharmaceuticals, Inc. (OCLS) Delisted Director 5,688 — — $0 4 2016-08-30
Sonoma Pharmaceuticals, Inc. (OCLS.W) Delisted Director 4,987 — — $0 5 2016-03-02

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-06-01 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +1,538 $0 EDGAR
2018-03-02 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +1,691 $0 EDGAR
2018-01-03 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +17,211 $0 EDGAR
2017-12-01 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +14,130 $0 EDGAR
2017-08-30 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +1,045 $0 EDGAR
2017-06-01 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +895 $0 EDGAR
2017-03-02 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +3,093 $0 EDGAR
2016-11-30 Sonoma Pharmaceuticals, Inc. (OCLSW) Delisted Grant (A) +1,229 $0 EDGAR
2016-08-30 Sonoma Pharmaceuticals, Inc. (OCLS) Delisted Grant (A) +1,423 $0 EDGAR
2016-06-01 Sonoma Pharmaceuticals, Inc. (OCLS) Delisted Grant (A) +5,090 $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.